Qifeng Yang
Overview
Explore the profile of Qifeng Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
313
Citations
7926
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang S, Zhang N, Wan T, He Y, Hao J, Liu Y, et al.
J Exp Clin Cancer Res
. 2025 Feb;
44(1):41.
PMID: 39910592
Background: D-2-hydroxyglutarate (D-2HG), an oncometabolite derived from the tricarboxylic acid cycle. Previous studies have reported the diverse effects of D-2HG in pathophysiological processes, yet its role in breast cancer remains...
2.
Wei F, Lin Z, Lu W, Luo H, Feng H, Liu S, et al.
Hypertension
. 2025 Jan;
PMID: 39758000
Background: Mechanosensitive Piezo1 channel plays a key role in pulmonary hypertension (PH). However, the role of Piezo2 in PH remains unclear. Methods: Endothelial cell (EC)-specific knockout (, Tek-Cre; ) rats...
3.
Long L, Wang L, Liang Y, Ye F, Jin Y, Luo D, et al.
Transl Oncol
. 2024 Dec;
52():102241.
PMID: 39674092
Background: Taxane-based chemotherapy is the primary treatment for triple-negative breast cancer (TNBC), yet clinical outcomes remain unsatisfactory due to the persistence of chemoresistance. Identifying key factors that contribute to chemoresistance...
4.
Li C, Wang X, Xing L, Chen T, Li W, Li X, et al.
Phytomedicine
. 2024 Sep;
135:156051.
PMID: 39299097
Background: Triple-negative breast cancer (TNBC) is the most intractable subgroup of breast neoplasms due to its aggressive nature. In recent years, immune checkpoint inhibitors (ICIs) have exhibited potential efficacy in...
5.
Jiang Q, Yang Q, Zhang C, Hou C, Hong W, Du M, et al.
Respir Res
. 2024 Jul;
25(1):288.
PMID: 39080603
Background: Chronic kidney disease (CKD) is a significant risk factor for pulmonary hypertension (PH), a complication that adversely affects patient prognosis. However, the mechanisms underlying this association remain poorly understood....
6.
Chen X, Ma C, Li Y, Liang Y, Chen T, Han D, et al.
Cell Death Dis
. 2024 Jul;
15(7):542.
PMID: 39079960
Breast cancer remains a significant global health challenge, and its mechanisms of progression and metastasis are still not fully understood. In this study, analysis of TCGA and GEO datasets revealed...
7.
Wang Z, Li Y, Yang J, Sun Y, He Y, Wang Y, et al.
Adv Sci (Weinh)
. 2024 Jul;
11(34):e2404628.
PMID: 38981022
Triple-negative breast cancer (TNBC) is the most malignant subtype of breast cancer. TP53, which has a mutation rate of ≈70%-80% in TNBC patients, plays oncogenic roles when mutated. However, whether...
8.
Liang Y, Ye F, Luo D, Long L, Wang Y, Jin Y, et al.
Mol Cancer
. 2024 Jun;
23(1):125.
PMID: 38849860
Background: Breast cancer is the most common malignant tumor, and metastasis remains the major cause of poor prognosis. Glucose metabolic reprogramming is one of the prominent hallmarks in cancer, providing...
9.
Li Y, Wang Z, Yang J, Sun Y, He Y, Wang Y, et al.
Mol Cancer
. 2024 May;
23(1):102.
PMID: 38755678
Peptides and proteins encoded by noncanonical open reading frames (ORFs) of circRNAs have recently been recognized to play important roles in disease progression, but the biological functions and mechanisms of...
10.
Zhang N, Harbers L, Simonetti M, Diekmann C, Verron Q, Berrino E, et al.
Nat Commun
. 2024 Apr;
15(1):3475.
PMID: 38658552
Somatic copy number alterations (SCNAs) are pervasive in advanced human cancers, but their prevalence and spatial distribution in early-stage, localized tumors and their surrounding normal tissues are poorly characterized. Here,...